FEIM vs. EYPT, ALNT, LAB, CTKB, AEHR, QSI, QTRX, SENS, MASS, and KEQU
Should you be buying Frequency Electronics stock or one of its competitors? The main competitors of Frequency Electronics include Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Aehr Test Systems (AEHR), Quantum-Si (QSI), Quanterix (QTRX), Senseonics (SENS), 908 Devices (MASS), and Kewaunee Scientific (KEQU). These companies are all part of the "measuring and control equipment" industry.
Frequency Electronics vs. Its Competitors
Eyepoint Pharmaceuticals (NASDAQ:EYPT) and Frequency Electronics (NASDAQ:FEIM) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings.
Eyepoint Pharmaceuticals has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500. Comparatively, Frequency Electronics has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500.
99.4% of Eyepoint Pharmaceuticals shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 4.5% of Eyepoint Pharmaceuticals shares are held by insiders. Comparatively, 26.1% of Frequency Electronics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Frequency Electronics has a net margin of 35.34% compared to Eyepoint Pharmaceuticals' net margin of -261.91%. Frequency Electronics' return on equity of 57.41% beat Eyepoint Pharmaceuticals' return on equity.
Eyepoint Pharmaceuticals presently has a consensus target price of $25.67, suggesting a potential upside of 132.07%. Given Eyepoint Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts plainly believe Eyepoint Pharmaceuticals is more favorable than Frequency Electronics.
Frequency Electronics has higher revenue and earnings than Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.
In the previous week, Frequency Electronics had 3 more articles in the media than Eyepoint Pharmaceuticals. MarketBeat recorded 9 mentions for Frequency Electronics and 6 mentions for Eyepoint Pharmaceuticals. Frequency Electronics' average media sentiment score of 0.69 beat Eyepoint Pharmaceuticals' score of 0.57 indicating that Frequency Electronics is being referred to more favorably in the news media.
Summary
Frequency Electronics beats Eyepoint Pharmaceuticals on 10 of the 16 factors compared between the two stocks.
Get Frequency Electronics News Delivered to You Automatically
Sign up to receive the latest news and ratings for FEIM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding FEIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Frequency Electronics Competitors List
Related Companies and Tools
This page (NASDAQ:FEIM) was last updated on 7/10/2025 by MarketBeat.com Staff
